Electronic Drug Delivery Systems Market Size Report, Industry Share, Analysis, Growth, 2030

Electronic Drug Delivery Systems Market

Electronic Drug Delivery Systems Market by Type (Electronic Autoinjectors, Electronic Wearable Infusion Pumps, Electronic Inhalers, and Electronic Injection Pens), and Indication (Multiple Sclerosis, Diabetes, Asthma & COPD, Cardiovascular Disease, and Other Indications): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-4878 Published Date: Oct-2019 Status : Published
Market Size in 2018 Market Forecast in 2025 CAGR (in %) Base Year
USD 7.2 Billion USD 13.3 Billion 9.2% 2018

Electronic Drug Delivery Systems Market

Electronic Drug Delivery Systems Industry Perspective:

The Global Electronic Drug Delivery Systems Market size accounted for USD 7.2 Billion in 2018 and is expected to reach USD 13.3 Billion by 2025, growing at a CAGR of 9.2% from 2019 to 2025.

Electronic Drug Delivery Systems Market: Overview

The report covers forecasts and analyses for the electronic drug delivery systems market on a global and regional level. The study provides historic data from 2016 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the electronic drug delivery systems market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the electronic drug delivery systems market on a global as well as regional level.

In order to give the users of this report a comprehensive view of the electronic drug delivery systems market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein the product and services segment is benchmarked based on their market size, growth rate, and general attractiveness.

Electronic Drug Delivery SystemsRequest Free Sample

The report provides a company market share analysis in order to give a broader overview of the key players in the electronic drug delivery systems market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the electronic drug delivery systems market on a global and regional basis.

Electronic Drug Delivery Systems Market:  Growth Factors

Electronic drug delivery systems (EDDS) are an important part of the innovation in the field of drug delivery systems. EDDS are interactive, portable, wirelessly connected, and enable patient-supervised therapy. These factors play a vital role in decreasing overall healthcare expenditures. EDDS has immense potential in the field of targeted drug delivery. By delivering optimum concentrations of doses to specific body parts, targeted drug delivery helps in reducing the dosage frequency of potentially harmful drugs.

Factors such as the growing incidence of target ailments, major advancements in the design of EDDS, increasing prevalence of chronic ailments, and positive reimbursement situation in developed regions will act as major driving factors in the growth of the global electronic drug delivery systems market. The application of EDDS in targeted drug delivery and increasing research and development initiatives will act as an opportunity for the market players in the electronic drug delivery systems market. Nonetheless, the high cost of electronic drug delivery systems, the need for maintenance, and the lack of awareness in low-income countries will restrict the growth of the global electronic drug delivery systems market.

Electronic Drug Delivery Systems Market: Report Scope

Report Attributes Report Details
Report Name Electronic Drug Delivery Systems Market Research Report
Market Size in 2018 USD 7.2 Billion
Market Forecast in 2025 USD 13.3 Billion
Growth Rate CAGR of 9.2%
Number of Pages 255
Forecast Units Value (USD Billion), and Volume (Units)
Key Companies Covered Medtronic plc, Insulet Corporation, Merck Group, Bayer AG, Novo Nordisk, AstraZeneca, United Therapeutics Corporation, Amgen, and Tandem Diabetes Care among others.
Segments Covered By Type, By Indication, By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)
Base Year 2018
Historical Year 2016 to 2018
Forecast Year 2019 - 2025
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Electronic Drug Delivery Systems Market: Segmentation

The global electronic drug delivery systems market has been split into type, indication, and region. Based on type, the electronic drug delivery systems market has been segmented into electronic autoinjectors, electronic wearable infusion pumps, electronic inhalers, and electronic injection pens.

The electronic wearable infusion pumps segment accounted for the highest market share in 2018 due to increasing diabetes incidence and the growing accessibility of commercial infusion pumps. The indication segment has been segmented into multiple sclerosis, diabetes, asthma & COPD, cardiovascular disease, and other indications.

The diabetes segment accounted for the highest market share in 2018 due to an increase in the number of diabetes cases around the world and the launch of new products.

North America will be the leading region during the forecast period. Quick uptake of new technologies, high prevalence of target disorders, easy availability of electronic drug delivery devices, and presence of leading market players will boost the market growth in this region. Europe will be the second largest market.

The major reasons are the existence of skilled physicians, growth in awareness concerning the use of electronic drug delivery devices, high diabetes incidence, and favorable reimbursement setup. The Asia Pacific will proliferate at a speedy rate over the forecast period due to fast technological improvements in the healthcare sector and swelling cases of asthma and other respiratory ailments.

The Latin American market will progress at a noteworthy rate during the estimated period. Middle Eastern and African countries are expected to experience noticeable growth in the projected time frame.

Electronic Drug Delivery Systems Market: Competitive Space

The report also includes detailed profiles of key players such as

  • Medtronic plc
  • Insulet Corporation
  • Merck Group
  • Bayer AG
  • Novo Nordisk
  • AstraZeneca
  • United Therapeutics Corporation
  • Amgen
  • Tandem Diabetes Care 
  • among others.

This report segments the Global Electronic Drug Delivery Systems Market as follows:

Global Electronic Drug Delivery Systems Market: By Type

Global Electronic Drug Delivery Systems Market: By Indication

  • Multiple Sclerosis
  • Diabetes
  • Asthma & COPD
  • Cardiovascular Disease
  • Other Indications

Global Electronic Drug Delivery Systems Market: By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of The Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Electronic drug delivery systems employ technology to precisely provide drugs to patients. These systems can distribute drugs via patches, inhalers, pumps, or other electronics that govern dosage, timing, and real-time data.

They increase patient compliance, tailor dose, and allow remote treatment monitoring and adjustment. These methods are beneficial for precision dosage or regulated pharmaceutical delivery over long durations.

Factors such as growing incidence of target ailments, major advancements in design of EDDS, increasing prevalence of chronic ailments, and positive reimbursement situation in developed regions will act as major driving factors in the growth of global electronic drug delivery systems market.

According to the report, the global demand for electronic drug delivery systems market was valued at approximately USD 7.2 Billion in 2018 and is expected to generate revenue of around USD 13.3 Billion by end of 2025, growing at a CAGR of around 9.2% between 2019 and 2025.

North America will be the leading region during the forecast period. Quick uptake of new technologies, high prevalence of target disorders, easy availability of electronic drug delivery devices, and presence of leading market players will boost the market growth in this region. 

The report also includes detailed profiles of key players such as Medtronic plc, Insulet Corporation, Merck Group, Bayer AG, Novo Nordisk, AstraZeneca, United Therapeutics Corporation, Amgen, and Tandem Diabetes Care among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed